GHOSH ANIRVAN (Chief Executive Officer) sold 0.6% of their position (432.00 shares) of UNITY BIOTECHNOLOGY, INC. on the open market
Open‑market sale worth $557.28 — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 11/6/2024ACC: 0000950170-24-122292
DirectorOfficer· Chief Executive Officer
Since Mar 2020
-432.00
Net shares
Net seller
$557.28
Total sold
1
Open market trades
0B · 1S
1
Total transactions
432.00 disposed
Non-Derivative Transactions1
Common Stock, $0.0001 par value
Direct
Shares
−432.00
Price / share
$1.29
Trade value
$557.28
% of position
0.6%
11/4/2024
76.33K→75.89K
Total
Net shares
−432.00
Net value
-$557.28
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock, $0.0001 par value Direct | 11/4/2024 | S · Sale | −432.00 | $1.29 | $557.28 | 0.6% | 76.33K | 75.89K |
| Total | −432.00 | -$557.28 | ||||||
Derivative Transactions0
No derivative transactions reported